Curaleaf Holdings CURLF
OTC CURLF
$9.83 +0.64 (+6.96%)
At close: Aug 19, 2026 · 3:59 PM UTC

Curaleaf Holdings (CURLF) Non-Current Deferred Tax Liability (2019 - 2026)

Curaleaf Holdings (CURLF) posted quarterly Non-Current Deferred Tax Liability of $212.0 million for Q4 2025, down 13.39% year-over-year from $244.8 million in Q4 2024, and down 13.39% quarter-over-quarter from $244.8 million in Q4 2024.

Curaleaf Holdings (CURLF) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends

Curaleaf Holdings' Non-Current Deferred Tax Liability history runs 7 years deep, the most recent figure standing at $212.0 million for Q4 2025.

  • In Q4 2025, Non-Current Deferred Tax Liability fell 13.39% year-over-year to $212.0 million; the TTM figure through Dec 2025 stood at $212.0 million (down 13.39% YoY), while the FY2025 annual figure was $212.0 million, down 13.39% from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 stood at $212.0 million, down from $244.8 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $342.6 billion in Q1 2022, with the low at $212.0 million in Q4 2025.
  • The 5-year median for Non-Current Deferred Tax Liability is $300.3 million (2021), against an average of $24.7 billion.
  • The sharpest annual moves came in 2022 and 2024: Non-Current Deferred Tax Liability surged 153837.26% in 2022, then slipped 17.64% in 2024.
  • Curaleaf Holdings' Non-Current Deferred Tax Liability stood at $257.8 million in 2021, then gained by 28.91% to $332.3 million in 2022, then decreased by 10.57% to $297.2 million in 2023, then fell by 17.64% to $244.8 million in 2024, then declined by 13.39% to $212.0 million in 2025.
  • Business Quant data shows CURLF's Non-Current Deferred Tax Liability at $212.0 million in Q4 2025, $244.8 million in Q4 2024, and $276.2 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn -
10 Curaleaf Holdings 2.48 Bn 2.38 Bn 169.91 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 129.22 Mn
Jun 30, 2026 129.22 Mn
Dec 31, 2025 212.00 Mn
Dec 31, 2025 212.00 Mn
Dec 31, 2024 244.77 Mn
Dec 31, 2024 244.77 Mn
Sep 30, 2024 276.22 Mn
Sep 30, 2024 276.22 Mn
Jun 30, 2024 285.59 Mn
Jun 30, 2024 285.59 Mn
Dec 31, 2023 297.19 Mn
Dec 31, 2023 297.19 Mn
Sep 30, 2023 311.04 Mn
Sep 30, 2023 311.04 Mn
Jun 30, 2023 318.21 Mn
Jun 30, 2023 318.21 Mn
Sep 30, 2022 332.31 Mn
Sep 30, 2022 332.31 Mn
Jun 30, 2022 334.81 Mn
Jun 30, 2022 334.81 Mn